A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies.
暂无分享,去创建一个
C. Britten | A. Patnaik | L. Siu | E. Rowinsky | L. Hammond | S. Eckhardt | F. Valone | A. Goetz | M. Villalona | S. Felton | S. Burton